Comparing Buprenorphine vs Xtampza ER
| Buprenorphine | Xtampza ER (oxycodone) |
|
|---|
| Buprenorphine | Xtampza ER (oxycodone) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Buprenorphine is a potent analgesic that should be only used to treat moderate to severe pain or for the treatment of opioid addiction under strict conditions. Different formulations of the drug... View more |
Prescription only
Prescribed for Chronic Pain, Pain. Xtampza ER may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||
| More about Buprenorphine | More about Xtampza ER (oxycodone) | ||||||||
| Ratings & Reviews | |||||||||
|
Buprenorphine has an average rating of 6.7 out of 10 from a total of 1154 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 25% reported a negative effect. |
Xtampza ER has an average rating of 3.9 out of 10 from a total of 169 ratings on Drugs.com. 24% of reviewers reported a positive effect, while 62% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Buprenorphine side effects |
View all Xtampza ER side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
Lower cost generic |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Buprenorphine prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Belbuca, Brixadi, Buprenex, Butrans, Sublocade | Other oxycodone brands include: Dazidox, Endocodone, ETH-Oxydose, Oxaydo, OxyContin, Oxydose, Oxyfast, Roxicodone, RoxyBond View more | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
48 hours |
5.6 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 726 drugs are known to interact with Buprenorphine:
|
A total of 624 drugs are known to interact with Xtampza ER:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
|
|||||||||
| First Approval Date | |||||||||
|
December 29, 1981 |
April 26, 2016 |
||||||||
| WADA Class View classifications | |||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.